Effectiveness of nebulizers in the treatment of respiratory tract infections in children of different ages

Objective: to study the effectiveness of compressor nebulizers in the treatment of respiratory tract respiratory infections in children of different age groups.

Material and methods: the main group consisted of 57 children - the average age was 9,7 ± 4,3 years, who were treated with nebulizer therapy using the compressor nebulizer during treatment, 32 children were included in the control group - the average age was 10,8 ± 4,7 years who have not been administered inhalation therapy. Along with conventional therapy, children of the main group underwent inhalation therapy using the compressor nebulizer in two modes, depending on the clinical symptoms of the patient: for bronchitis, the course was 5-6 days, for pneumonia - up to 8-9 days. Using the compressor nebulizer, physiological saline, ipratropium bromide, berodual, pulmicort, lasolvan were injected in a constant flow mode, and in cases of diagnosed rhinosinusitis, a pulsed aerosol delivery regime was used.

Results: when analyzing the clinical picture, it was revealed that in all patients the process took a torpid course with prolonged unproductive cough, viscous sputum and persistently retained auscultatory data with insignificant changes in the general blood test. Analysis of the obtained data on the use of various treatment regimens for nosological forms of diseases in the examined children showed that in the patients of the main group the clinical symptoms of a combination of pulmonary diseases and rhino-sinusitis were stopped when applying the pulsating delivery regimen in terms of 6,1 ± 0,7 days (p<0.05), in cases of isolated variants of bronchitis and pneumonia, the use of a constant flow regime reduced the hospitalization of children to 82 ± 7,4% of the standard indicators of bed days.

Conclusion: our own studies on the effectiveness of inhalation therapy in children revealed a wide range of clinical effects using the compressor nebulizer, regardless of the age of the patient: the clinical symptoms of a combination of pulmonary diseases and rhinosinusitis were stopped by using a pulsating delivery regimen in a shorter time compared to the control group without inhalation therapy, which reduced the hospitalization of children in the hospital.

1. Bilichenko T.N., Bystritskaya E.V., Chuchalin A.G., Belevskiy A.S., Batyn S.Z. Mortality of respiratory disease in 2014-2015 and ways of its improvement. Russian Pulmonology. 2016;26(4):389-397. (In Russ.) doi: 10.18093/0869-0189-2016-26-4-389-397.

2. Current inhalational devices for treatment of respiratory disease. Task Force report of European Respiratory Society and the International Society for Aerosols in Medicine. Russian Pulmonology. 2011;(6):17-41. (In Russ.) Available at: https://journal.pulmonology.ru/pulm/article/view/414.

3. Vavilova V.P., Karaulova T.A. Advantages of nebulizer therapy in the treatment of children with adeno-tonzillary pathology. Rossiyskaya otorinolaringologiya = Russian otorhinolaryngology. 2012;(3):29-32. (In Russ.) Available at: https://elibrary.ru/item.asp?id=17902516.

4. Geppe NA., Mokina NA. Modern inhalation therapy. Practical Guidelines for Doctors. М.: GEOTAR-Media; 2012. 128 p. (In Russ.) Available at: https://search.rsl.ru/ru/record/01008782050.

5. Trushenko N.V., Belevsky A.S. Which nebulizer to choose and how to use it. Asthma and allergies. 2019;(3):19-21. (In Russ.) Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles/astma/Asthma_3_2019_19.pdf.

6. Nurislamova E.N., Melnikova OA. Nebulizer and inhalation therapy in children's practice. Modern Science. 2019;12(2):115-117. (In Russ.) Available at: https://elibrary.ru/item.asp?id=41569474.

7. Kolosova N.G., Geppe N.A. Nebulizer therapy in pediatric practice. RMZH = RMJ. 2011;19(8):514-517. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Terapiya_nebulayzerami_v_pediatricheskoy_praktike.

8. Terekhova E.P., Bodnya O.S., Terekhov D.V., Nenasheva N.M. Possibilities of nebulizer therapy for bronchial asthma. Ehffektivnaya farmakoterapi-ya. Allergologiya i immunologiya = Effective pharmacotherapy. 2018;(1):30-39. (In Russ.) Available at: https://umedp.ru/articles/vozmozhnosti_nebu-layzernoy_terapii_bronkhialnoy_astmy_html.

9. Misernitsky Yu.L., Melnikova I.M., Loginevskaya Y.V, Batozhargalova B.Ts., Kozlova L.A. Clinical efficacy of combination mucoactive expectorant therapy in children with acute lower respiratory tract respiratory infections. Lechashchiy vrach = Attending Doctor. 2011;(11):107-112. (In Russ.) Available at: https://www.lvrach.ru/2011/11/15435318/

10. Misernitsky Yu.L. New opportunities for nebulizer therapy in children. Meditsinskiy sovet = Medical Council. 2019;(2):87-89. (In Russ.) doi: 10.21518/2079-701X-2019-2-87-89.

11. Fesenko O.V. Possibilities of modern mesh nebulizers. Consilium medicum. 2018;20(11):52-54. (In Russ.) Available at: https://goo-gl.su/kp255tE

12. Kutsenko M.A., Chuchalin A.G. Nebulizers and inhalation therapy in pulmonological practice. RMZH = RMJ. 2013;21(29):1440-1445. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Nebulayzery_i_ingalyacion-naya_terapiya_v_pulymonologicheskoy_praktike/

13. Zaitsev A.A., Kharitonov M.A., Chernetsov V.A., Kryukov E.V. Modern possibilities of nebulizer therapy. Meditsinskiysovet = Medical Council. 2019;(15):106-111. (In Russ.) doi: 10.21518/2079-701X-2019-15-106-111.

14. Pikuza O.I., Zakirova A.M. Modern approaches to cough therapy in medical practice. Breast cancer. 2017;25(18):1312-1316. (In Russ.) Available at: https://elibrary.ru/download/eli-brary_30397504_76778695.pdf.

15. Galimova L.F., Pikuza O.I., Suleymanova Z.Ya., Zakirova A.M., Samorodnova E.A. The indicator role of cell contents in nasal secretion in acute bronchitis and community-acquired pneumonia in children. Lechashchiy vrach = Attending Doctor. 2017;(11):55-58. (In Russ.) Available at: https://www.lvrach.ru/2017/11/15436851/